All Episodes

HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment

Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors

Breast Cancer — An ASCO 2025 Review

Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting

Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Metastatic BRCA-Negative, Triple-Negative Breast Cancer — An Interview with Prof Peter Schmid on Optimal Management

Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management

Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy

Metastatic Triple-Negative Breast Cancer — The Selection and Sequencing of Therapy

Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management

Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 2 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders: Part 1

Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason

Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients

Biliary Tract Cancers — Expert Perspectives on Actual Patient Cases: Part 2 of 2

Brain Metastases with HER2-Positive Breast Cancer — An Interview with Dr Sarah Sammons on Optimal Management Approaches

Small Cell Lung Cancer — Expert Perspectives on Actual Patient Cases

Ovarian and Endometrial Cancer — An Interview with Dr Shannon Westin on the Current Management Paradigm

Non-Small Cell Lung Cancer — 5-Minute Journal Club Issue 1 with Dr Jacob Sands: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Multiple Myeloma | Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma

Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Multiple Myeloma — Optimizing the Selection of First-Line Therapy

Breast Cancer — 5-Minute Journal Club Issue 1 with Dr Erika Hamilton: Defining the Role of TROP2-Directed Antibody-Drug Conjugates

Gynecologic Cancers — Year in Review Series on Relevant New Datasets and Advances

Oncology Nursing Update: Prostate Cancer — An Interview with Ms Kathleen D Burns on the Current Treatment Paradigm and New Approaches to Patient Care

Endocrine-Resistant HR-Positive Metastatic Breast Cancer — An Interview with Dr Hope S Rugo on Optimal Management

Soft Tissue Sarcoma and Other Connective Tissue Neoplasms — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Renal Cell Carcinoma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Chronic Lymphocytic Leukemia — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Oncology Nursing Update: Ovarian Cancer — An Interview with Ms Jennifer Filipi on the Current Treatment Paradigm and New Approaches

Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting

Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting on the Current and Future Role of Immunotherapy and Antibody-Drug Conjugates

For Oncology Nurses: Prostate Cancer — Proceedings from the 2025 Annual ONS Congress

HER2-Positive Gastrointestinal Cancers — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress

Urothelial Bladder Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: DLL3-Targeting Bispecific T-Cell Engagers for Small Cell Lung Cancer — Proceedings from the 2025 Annual ONS Congress

For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress

Metastatic Breast Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Colorectal Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Ovarian and Endometrial Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress

Prostate Cancer  — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

For Oncology Nurses: Ovarian Cancer — Proceedings from the 2025 Annual ONS Congress

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting

Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances

For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress

For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress

Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances

Non-Small Cell Lung Cancer and Therapeutic Targets Beyond EGFR — Year in Review Series on Relevant New Datasets and Advances

For Oncology Nurses: Endometrial Cancer — Proceedings from the 2025 Annual ONS Congress

Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances

Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances

Prostate Cancer and AKT Inhibitors — Proceedings from a Session Held During the American Urological Association Annual Meeting

Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit

Hepatocellular Carcinoma — Fourth Annual National General Medical Oncology Summit

Multiple Myeloma — Fourth Annual National General Medical Oncology Summit

For Oncology Nurses: Pancreatic Cancer — Proceedings from the 2025 Annual ONS Congress

Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Gastroesophageal Cancer — Fourth Annual National General Medical Oncology Summit

Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies

Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit

Pancreatic Cancer — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit

Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit

Prostate Cancer — Fourth Annual National General Medical Oncology Summit

Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies

Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates

Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2

Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️

Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit

HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit

Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit

Neuroendocrine Tumors — Fourth Annual National General Medical Oncology Summit